News
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
1don MSN
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
DALLAS, TX (IANS) – Low-dose acetylsalicylic acid, also known as aspirin, may reduce inflammation among people suffering from sleep loss, according to a new study on June 10. The findings, presented ...
Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...
A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of gut cancer recurrence after tumour surgery.
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria ...
New research shows a common over-the-counter drug may have significant benefits for people with colon and rectal cancer.
The Chosun Ilbo on MSN
Aspirin offers no long-term cardiovascular benefit for healthy elderly
Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed arteries and blood clots (thrombi) that block blood flow. Aspirin is known as a ...
Daily aspirin can cut in half the risk that colon cancer will come back. Risk of recurrence was 55% lower in people who took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results